Serratipeptidase Tablets 5 mg Manufacturer

Serratipeptidase Tablets 5 mg Manufacturer in India – Healthy Life Pharma Pvt. Ltd.

Serratipeptidase Tablets 5 mg Manufacturer product packaging

Serratipeptidase Tablets 5 mg | Manufacturer

Product image for Serratipeptidase Tablets 5 mg Manufacturer; contract manufacturing, oem & quality control.

Product Information

Generic NameSerratipeptidase
ManufacturerHealthy Life Pharma Pvt. Ltd.
HSN Code30049099
PharmacopoeiaIP / BP
Product TypeTablet
CategoryAnalgesic and Anti-inflammatory drugs
SubcategoryAnalgesic and Anti-inflammatory drugs
Active IngredientSerratipeptidase
Strength5 mg
Dosage FormTablet
Pack Size10 x 10 Tablets / Box (Alu-Alu / Blister)
Route of AdministrationOral
Prescription RequiredYes
Therapeutic CategoryAnalgesic and Anti-inflammatory drugs

Medicine Details & Safety

Short DescriptionHealthy Life Pharma invites contract and third-party manufacturing enquiries for Serratipeptidase Tablets 5 mg from pharmaceutical marketing companies, institutional buyers and brand owners. Production specifications, batch size and packaging are agreed against the approved product dossier and purchase requirements.
Approved Uses / Indications1. Relief of pain and functional stiffness in osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. 2. Management of acute painful musculoskeletal disorders, tenosynovitis, lumbago, dentalgia, and post-traumatic injury.
Full Description

Healthy Life Pharma invites contract and third-party manufacturing enquiries for Serratipeptidase Tablets 5 mg from pharmaceutical marketing companies, institutional buyers and brand owners. Production specifications, batch size and packaging are agreed against the approved product dossier and purchase requirements.

Product technical specifications

Generic nameSerratipeptidase
CompositionSerratipeptidase
Strength5 mg
CategoryAnalgesic and Anti-inflammatory drugs
PharmacopoeiaIP / BP
Dosage formTablet

Product technical specifications

Generic nameAcarbose
CompositionAcarbose
Strength25 mg
CategoryAntidiabetic Drugs
PharmacopoeiaUSP / IP
Dosage formTablet

Manufacturing capabilities and infrastructure

For Serratipeptidase Tablets 5 mg, assess the approved formulation process, equipment suitability, batch scale and in-process controls for the Tablet presentation. Confirm environmental requirements and validated process before production.

Quality control and assurance

Request the approved finished-product specification for Serratipeptidase Tablets 5 mg, including applicable identity, assay, uniformity and performance tests for the Tablet presentation. Confirm analytical methods, acceptance criteria and batch release documentation, including COA availability.

Primary and secondary packaging

The catalogue pack for Serratipeptidase Tablets 5 mg is 10 x 10 Tablets / Box (Alu-Alu / Blister). Confirm primary packaging compatibility, stability evidence, artwork, batch coding and leaflet requirements against the approved specification.

Contract manufacturing and private label

Submit the target market, strength, pharmacopoeial specification, forecast volume and brand artwork. Agree feasibility, batch size, quality agreement, production schedule and release criteria before execution.
Dosage InstructionsAdminister orally with a full glass of water, preferably with or immediately following meals to minimize gastric irritation. Do not exceed the maximum prescribed daily dosage. Use the lowest effective dose for the shortest treatment duration necessary.
Side EffectsCommon: Epigastric discomfort, dyspepsia, heartburn, nausea, abdominal pain. Uncommon: Dizziness, headache, mild diarrhea, flatulence, constipation. Rare: Peptic ulceration, gastrointestinal hemorrhage, elevated transaminases, hypersensitivity rash.
Warnings and PrecautionsGastrointestinal Safety: Long-term administration can lead to gastric mucosal erosion, ulceration, or bleeding. Cardiovascular & Renal Caution: Use with caution in patients with preexisting hypertension, congestive heart failure, or renal compromise. Monitor renal parameters periodically.
Contraindications1. Known hypersensitivity to Serratipeptidase, aspirin, or other NSAIDs.
2. Active peptic ulcer disease, gastrointestinal hemorrhage, or history of perforation.
3. Severe heart failure (NYHA Class III-IV), severe hepatic cirrhosis, or advanced renal failure.
4. Third trimester of pregnancy.
Drug Interactions1. Anticoagulants & Antiplatelets (Warfarin, Clopidogrel): Increased risk of serious GI bleeding.
2. ACE Inhibitors, ARBs & Diuretics: Attenuated antihypertensive efficacy and increased nephrotoxicity risk.
3. Methotrexate & Lithium: Reduced renal clearance causing elevated serum concentrations and toxicity.

Frequently Asked Questions

QuestionAnswer
Can I request third-party manufacturing for Serratipeptidase Tablets 5 mg?Submit your brand, quantity and packaging requirements for manufacturing feasibility review.
Which pharmacopoeial standard applies for Serratipeptidase Tablets 5 mg?The source specification is IP / BP; confirm the required standard before contracting.
What quality tests are applicable for Serratipeptidase Tablets 5 mg?Request the approved finished-product specification and batch testing plan.
Can packaging be customized for Serratipeptidase Tablets 5 mg?Submit artwork and pack requirements for technical and regulatory review.
How do I request a manufacturing quotation for Serratipeptidase Tablets 5 mg?Provide forecast volume, target market, strength and packaging requirements.

Product Tags

Serratipeptidase Tablets 5 mg ManufacturerSerratipeptidase 5 mgContract ManufacturingOEM & Quality ControlHealthy Life Pharma Pvt. Ltd.

Product Hashtags

#Serratipeptidase#Manufacturer#PharmaB2B

Related Products

Latest Posts